Orforglipron (LY3502970) is a small-molecule, non-peptide GLP-1RA designed for oral use. Compared to popular GLP-1RAs like semaglutide, orforglipron does not require injection or an absorption ...
Share on Pinterest GLP-1s linked to higher osteoporosis risk but they may bring some benefits, too, new studies find. Image credit: SweetBunFactory/Getty Images A large percentage of Americans are ...
Noom has launched a new Proactive Health GLP-1 Program focused on preventive health care. The program includes at-home testing of 17 biomarkers, behavioral support, and personalized GLP-1 microdosing ...
Share on Pinterest Research suggests that GLP-1 drugs likely have little to no effect on risk for obesity-related cancers. Image credit: James Manning – PA Images/Getty Images In 2022, about 2.5 ...
The growing use of GLP-1 drugs for weight loss is boosting demand for nutrient-dense foods, presenting opportunities for ...